Fluorescent chelates of europium, terbium, and samarium are potential alternatives to isotopic labels, conventional fluorophores, and other nonisotopic labels for immunological and other assays. The main advantages of these fluorescent lanthanide chelates are shown in Table 1 . By combining the advantages listed, background fluorescence can be virtually eliminated ( Figure   1 ). Thus, a pulsedlight time-resolved fluorometric measurement of a europium chelate is at least 103-fold more sensitive than is a measurement based on conventional fluorometry. #{149} Apart from the requirement that the chelata be fluorescent, it must also possess very high stability; otherwise, during the washing process necessary for heterogeneous iinmunoassays, Eu3 would leak into the solution. The system, known as DELFIA (Pharmacia-LKB, Bromma, Sweden) has excellent sensitivity, broad dynamic range, and reagent stability.
Lanthanide
The excellent sensitivity is due to the fact that, during the immunoreaction, Eu3 is carried on the antibody tightly bound to a strong chelator without any leakage. Also, during measurement, Eu3 is optimally complexed by organic hgands to form a highly fluorescent complex. However, this system has been criticized for three reasons: (a) An extra step is needed to extract Eu3 from the solid phase before measurement; (b) more importantly, the final measurement is based on Eu3 quantification, usually at 10-12 1O_13 mol/L, but because Eu3 is a natural element present in dust, skin, etc., the possibility of contamination, especially of the reagents containing the europium chelators, presents difficulties;
(c) because the final measurement is based on extraction, the system is not suitable for other biospecific assays, e.g., Southern, Northern, or Western blotting, DNA sequencing, or immunohistochemistry and flow cytometry. Immunoassays wIth BCPDA-Labeled DetectIon
AntIbodIes
About six years ago, we started research towards the synthesis of organic europium chelators that would combine good complex stability and energy transfer so that we could achieve assays based on the design of Figure 2 without the need for extraction of Eu3. Such efforts have also been undertaken by other groups; isolated reports are described by Soini et al. (5) . The best chelator identilled by our group, BCPDA, was synthesized as shown in Figure 3 Earlier reports by our group established optimal procedures for labeling proteins with BCPDA (7). In general, we found it easy to derivatize all amino groups of many different proteins; however, for biologically active mac- tensive labeling results in partial or full loss of biological activity. Thus, optimal labeling is mandatory, not just desirable (7 Figure 2) , with the fluorescent immunocomplex measured directly on the solid phase. Although it was clearly established that in such assays, with BCPDA as label, the immunocomplex does not lose Eu3 during repeated washing and is fluorescent so that there was no need for Eu3 extraction (unpublished data), the configuration was not highly sensitive. We attributed the low sensitivity partly to the fact that only 1:1 complexes of Eu3 with BCPDA could form because of the presence of excess Eu3.
The issue of low sensitivity was addressed in a series of efforts to amplifr the above system so that highly sensitive assays could be achieved.
Antibody Labeling
Antibodies possess many s-amino groups (>50 per molecule) but derivatization of >18 per molecule with BCPDA inactivates the antibody. We decided to increase the antibody load by covalently linking it with a carrier protein that is already highly labeled with BCPDA. The conjugation chemistry used is diagrammatically shown in Figure 4 . For the carrier protein, we used bovine serum albumin, which could carry as many as 40 BCPDA molecules ( Figure 5) (9) .
Biotin-Streptavidin System
This versatile system has recently been reviewed (10). In most immunoassay applications, biotin is introduced into detection antibodies at a load of 10-20 biotins per antibody, by reacting the s-amino groups of lysines with an N-hydroxysuccinimide ester of biotin in a very simple one-step reaction. Streptavidin (SA), labeled with a reporter molecule, is added in a separate step to bind to biotin and thus reveal the presence of the imniunocomplex. A final immunocomplex on the solid phase for an aipha-fetoprotein assay is shown in Figure 6 (left 
Streptavidin Labeling
In our previous studies of labeling various proteins with BCPDA (7), we noticed that we could easily incorporate into the proteins as many or, in some instances, no overlap between the excitation and emission spectra. Second, the fluorescence found was not just proportional to the degree of multiple labeling with BCPDA but was about three-to sixfold greater. This "bonus effect" was considered to be related to environmental effects of the various amino acids around the Eu3 and BCPDA.
Bovine thyroglobulin (TG) is a high-Mr protein (660 000
Da) carrying -150 s-amino groups (7). We were able to introduce --175 BCPDA labels per molecule of TG and obtain fluorescence equivalent to that obtained by -900 BCPDA residues, with excess Eu3. We decided to create a new biotin-binding protein that could carry not just 14 BCPDA molecules but -150, instead. We covalently linked streptavidin to BCPDA-labeled TG with an elegant conjugation chemistry shown in Figure 7 and further described elsewhere (11). The new streptavidin reagent, represented by the formula SA(TGXBCPDA)ise, gave signal amplification and detection limit improvement by about fivefold that of SA(BcPDA)14 (directly labeled streptavidin).
Obviously, some steric hindrance effects of streptavidin binding do occur with this newer reagent, but the benefits are quite significant (Figure 6 , right).
Streptavidin-Based Macromolecular Complex (SBMC)
A serendipitous observation during accelerated stability studies with the reagent SA(TG)(BcPDA)1 led to the development of an SBMC, which now is our reagent of jugation of streptavidin. Routinely, we do not remove the excess of thiolated-BCPDA-labeled TG because we have not observed any significant increase in the background signal with its presence. However, when we added Eu3' to the final reaction mixture after conjugation, which contained SAcrG)(BcPDA)1 and TG(BcPoA)1, and incubated at 50-55 #{176}C for a few hours, we observed that a new, more sensitive reagent is formed under controlled reaction conditions, especially when Eu3 concentration is carefully controlled. After extensive studies (14), we proposed that under such conditions, a SBMC is formed (Figure 8 Results are summarized in Table 3 . The last-named reagent improved both signal amplification and detection limits by eight-to 26-fold compared with SA(TG)(BCPDA)jso. Using the SBMC in an alpha-fetoprotein assay designed to maximize sensitivity, we were able to detect -300 000 molecules (-2 amol) of alpha-fetoprotein (15), which is the lowest detection limit reported for any time-resolved fluorometric assay (Table 4 ). The SBMC can be used in any application in which a biotinylated reactant is used.
Documented applications other than immunoassay include DNA hybridization2
and Western blotting.
Currently, the same reagent is being evaluated for Northern blotting, DNA sequencing, and detection of PCR products. Other possible applications include flow-cytometry and inununohistochemistry.
Further Amplification Strategies
We have also extensively investigated strategies that could increase the biotinylation load. This increased biotinylation load, in combination with the SBMC, should yield even further total amplification of the proposed detection system. Among the many possibilities tested, two produced useful results.
The principle of the first approach is shown in Figure  9 . Anti-lutropin detection antibodies are labeled with to enzyme-based systems because they do not need special conditions of temperature control, exact timing, or extra steps for substrate incubation. In addition, the system described here is completely contssmination-free because the label (BCPDA) is a compound not present in nature-another advantage over both the Eu3-and the enzyme-based assays. The system I have However, the dotection limit was improved by only about three-to sixfold
